<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Epidermal growth factor (EGF) in saliva is cytoprotective against injuries and contributes to the maintenance of the integrity of the gastrointestinal mucosa </plain></SENT>
<SENT sid="1" pm="."><plain>Low salivary EGF levels have been observed in patients with various forms of oral <z:e sem="disease" ids="C0151785" disease_type="Disease or Syndrome" abbrv="">mucosal disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: Our aim was to determine whether salivary EGF is low in patients with <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> (<z:mp ids='MP_0011356'>RAS</z:mp>) or those with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) when compared with healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The study population consisted of 33 BD and 16 <z:mp ids='MP_0011356'>RAS</z:mp> patients and 60 healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Measurement of EGF concentration in human saliva was performed with an enzyme-linked immunosorbent assay using an antibody-coated solid phase </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The mean salivary EGF levels (+/-SD) of active (with <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulceration</z:e>) and inactive stages (absence of <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulceration</z:e>) of BD (1,939.7 +/- 1,561.5 and 2,305.7 +/- 1,481.6 pg/ml, respectively) and <z:mp ids='MP_0011356'>RAS</z:mp> patients (1,650.5 +/- 704.7 and 1,069.9 +/- 539.2 pg/ml, respectively) were both lower than those of the healthy controls (2,758.7 +/- 1,657.9 pg/ml) (p &lt; 0.05 for each) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: BD and <z:mp ids='MP_0011356'>RAS</z:mp> patients have reduced salivary EGF levels even in the absence of <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulcerations</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>EGF could be involved in the pathogenesis of BD and <z:mp ids='MP_0011356'>RAS</z:mp> by disturbing the mucosal integrity that may result in a susceptibility to the development of <z:hpo ids='HP_0000155'>oral ulcers</z:hpo> in these diseases </plain></SENT>
</text></document>